CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors

por O'Dwyer, R.T., Connolly, W., Hamilton, S., Kelly, S., Lynch, A., Martin, F., Dempsey, K., Rondthaler, A., Ryan, B., Byrne, A., Corrigan, R., Lawless, R., Conlon, L., Hickey, P., Manning, A., Egan, K., Breathnach, O.S., O'Shea, C., Christie, A., Treanor, L.
Publicado 2021